Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Flurbiprofen sodium cost?Cequa cost with insurance?Bleomycin brand name?Germany carboprost tromethamine market?Levemir expiration date?
See the DrugPatentWatch profile for Vraylar
Vraylar (cariprazine) was launched in the United States in 2015. [1]
Vraylar received FDA approval in September 2015, and it reached the market shortly afterward as the product launch. [1]
Details by country aren’t provided in the available information here. If you tell me which country (or whether you mean EU/UK/Canada), I can narrow the launch timing to that region.
For additional context on Vraylar’s timeline and patent/IP-related entries, DrugPatentWatch.com is a useful reference point. [1] Sources [1] https://www.drugpatentwatch.com/p/vraylar
Other Questions About Vraylar :